BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 35674826)

  • 1. The immunology of Parkinson's disease.
    Zhu B; Yin D; Zhao H; Zhang L
    Semin Immunopathol; 2022 Sep; 44(5):659-672. PubMed ID: 35674826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
    Çınar E; Tel BC; Şahin G
    Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.
    Brockhausen I; Schutzbach J; Wang J; Fishwick B; Brockhausen J
    Glycoconj J; 2022 Feb; 39(1):55-74. PubMed ID: 34757539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
    Yi S; Wang L; Wang H; Ho MS; Zhang S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal infection triggers mitochondria-mediated α-synuclein pathology: relevance to Parkinson's disease.
    D Magalhães J; Candeias E; Melo-Marques I; Silva DF; Esteves AR; Empadinhas N; Cardoso SM
    Cell Mol Life Sci; 2023 May; 80(6):166. PubMed ID: 37249642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
    Zheng T; Zhang Z
    Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].
    Qiao S; Luo JH; Jin JH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):210-4. PubMed ID: 22499522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.
    Sian-Hulsmann J; Riederer P
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions.
    Gadhavi J; Patel M; Bhatia D; Gupta S
    Biochimie; 2022 Jan; 192():38-50. PubMed ID: 34582997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of α-Synuclein Aggregation in the Peripheral Tissues.
    Li YY; Zhou TT; Zhang Y; Chen NH; Yuan YH
    Neurochem Res; 2022 Dec; 47(12):3627-3634. PubMed ID: 35348944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in Parkinson's disease induced by α-synuclein transmitted through the gut-brain axis].
    Zhou J; Wang Z
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2120-2127. PubMed ID: 35786466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet in Parkinson's disease: Insights into pathophysiology & theranostic solutions.
    Beura SK; Panigrahi AR; Yadav P; Singh SK
    Ageing Res Rev; 2022 Sep; 80():101681. PubMed ID: 35798236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain.
    Espinosa-Oliva AM; Ruiz R; Soto MS; Boza-Serrano A; Rodriguez-Perez AI; Roca-Ceballos MA; García-Revilla J; Santiago M; Serres S; Economopoulus V; Carvajal AE; Vázquez-Carretero MD; García-Miranda P; Klementieva O; Oliva-Martín MJ; Deierborg T; Rivas E; Sibson NR; Labandeira-García JL; Machado A; Peral MJ; Herrera AJ; Venero JL; de Pablos RM
    Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12962. PubMed ID: 38343067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.